Literature DB >> 21113606

Nanomedicine in otorhinolaryngology: what does the future hold?

Carl M Philpott1, Simon Gane, David McKiernan.   

Abstract

Nanotechnology and nanomedicine are new and rapidly developing areas which are concerned with the utilisation of structures and devices, one billionth of a metre in scale and how their special properties may be utilised in the diagnosis and treatment of diseases. In otorhinolaryngology, there have been some inroads into utilising these new treatment modalities and there is future prospect for significant developments. Their impact may be to revolutionise the current practice of otorhinolaryngology. This review considers current developments and future prospects for nanotechnology in our specialty and considers the pitfalls that may be encountered. The online medical reference databases PubMed, Google Scholar, ISI Web of Science and Science Direct were searched with search terms "Nanotechnology, Nanomedicine" in combination with "Otolaryngology, ENT, Rhinology, Otology, Head and Neck Surgery, Laryngology" in turn. A number of developments are already showing promise in animal models, particularly for nanoparticle delivery of drugs, which may avoid some of the inherent systemic side effects seen with conventional application. Other possibilities include nanoscale reconstruction and regeneration of tissues and even unexpected spin-off technologies such as haemostatic agents. The future treatment of otorhinolaryngological diseases could be revolutionised by advances in nanomedicine and nanotechnology and diseases, such as olfactory disorders may become radically more amenable to medical treatment.

Entities:  

Mesh:

Year:  2010        PMID: 21113606     DOI: 10.1007/s00405-010-1418-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  55 in total

1.  Multiple label-free biodetection and quantitative DNA-binding assays on a nanomechanical cantilever array.

Authors:  Rachel McKendry; Jiayun Zhang; Youri Arntz; Torsten Strunz; Martin Hegner; Hans Peter Lang; Marko K Baller; Ulrich Certa; Ernst Meyer; Hans-Joachim Güntherodt; Christoph Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

2.  From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine.

Authors:  Chiming Wei; Nanhai Liu; Pingyi Xu; Mike Heller; Donald A Tomalia; Donald T Haynie; Esther H Chang; Kuan Wang; Yoon-Sik Lee; Yuri L Lyubchenko; Raj Bawa; Ryan Tian; Justin Hanes; Suzie Pun; Jens-Christian Meiners; Peixuan Guo
Journal:  Nanomedicine       Date:  2007-12       Impact factor: 5.307

Review 3.  The cytoskeleton in cancer cells.

Authors:  A Ben-Ze'ev
Journal:  Biochim Biophys Acta       Date:  1985

4.  Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study.

Authors:  M E Shykhon; D W Morgan; R Dutta; E L Hines; J W Gardner
Journal:  J Laryngol Otol       Date:  2004-09       Impact factor: 1.469

5.  Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.

Authors:  Jens U Ponikau; David A Sherris; Amy Weaver; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

6.  Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.

Authors:  Fenna A Ebbens; Glenis K Scadding; Lydia Badia; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Marcel G W Dijkgraaf; Valerie Lund; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

7.  Effect of zinc sulfate on sensorineural olfactory disorder.

Authors:  T Aiba; M Sugiura; J Mori; K Matsumoto; K Tomiyama; F Okuda; Y Nakai
Journal:  Acta Otolaryngol Suppl       Date:  1998

8.  Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.

Authors:  Subinoy Das; Patricia A Maeso; Adam M Becker; John D Prosser; Bao-Ling Adam; Stilianos E Kountakis
Journal:  Laryngoscope       Date:  2008-12       Impact factor: 3.325

9.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.

Authors:  Craig A Poland; Rodger Duffin; Ian Kinloch; Andrew Maynard; William A H Wallace; Anthony Seaton; Vicki Stone; Simon Brown; William Macnee; Ken Donaldson
Journal:  Nat Nanotechnol       Date:  2008-05-20       Impact factor: 39.213

10.  Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B.

Authors:  Eugene B Kern; David Sherris; Angelos M Stergiou; Laura M Katz; Lisa C Rosenblatt; Jens Ponikau
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

View more
  1 in total

1.  Homeopathic medications as clinical alternatives for symptomatic care of acute otitis media and upper respiratory infections in children.

Authors:  Iris R Bell; Nancy N Boyer
Journal:  Glob Adv Health Med       Date:  2013-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.